Answer
Vizimpro (dacomitinib monohydrate) selectively and irreversibly inhibits EGFR/HER1, HER2 and HER4.
Sources for this answer
- Vizimpro 15mg film-coated tabletsPfizer Limited · emc · SmPC §5.1 Pharmacodynamic properties · Version 5Document updated
Sources checked